← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2007Last known activity
Oct 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (14 distinct, 11 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT06578182Lead sponsorPhase 3Oct 1, 2024
- NCT06172010CollaboratorPhase 4Apr 1, 2023
- NCT05533164Lead sponsorPhase 3Jan 31, 2023
- NCT05533125Lead sponsorPhase 3Jan 31, 2023
- NCT05345249Overall official - principal investigatorPhase 4Jun 1, 2022
- NCT05345249Lead sponsorPhase 4Jun 1, 2022
- NCT05345249Sponsor investigatorPhase 4Jun 1, 2022
- NCT04222920CollaboratorPhase 4Feb 1, 2020
- NCT04222920Lead sponsorPhase 4Feb 1, 2020
- NCT04222920Overall official - principal investigatorPhase 4Feb 1, 2020
- NCT04194827Lead sponsorPhase 4Dec 3, 2019
- NCT04194827Overall official - principal investigatorPhase 4Dec 3, 2019
- NCT04194827CollaboratorPhase 4Dec 3, 2019
- NCT03895879Lead sponsorPhase 4Jul 31, 2019
- NCT03895879Overall official - principal investigatorPhase 4Jul 31, 2019
Details
- Founded
- Amsterdam, NL
- Last known activity
- Oct 1, 2024